Autologous CD19‐ targeting CAR T cells in refractory juvenile dermatomyositis
0
Authors
Rebecca Nicolai
Rebecca Nicolai•Emiliano Marasco•Franco Locatelli
Published
June 25, 2024
Abstract
The aim of this study is to report the safety and efficacy of CD19-targeting chimeric antigen receptor (CAR) T cells in a child with refractory juvenile dermatomyositis (JDM).
